|
Volumn 36, Issue 1, 2015, Pages 11-12
|
Nontuberculous mycobacteria
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVERSE OUTCOME;
ANTIMICROBIAL THERAPY;
ATYPICAL MYCOBACTERIOSIS;
ATYPICAL MYCOBACTERIUM;
BACTERIAL GROWTH;
BACTERIUM ISOLATION;
CYSTIC FIBROSIS;
DRUG MONITORING;
EDITORIAL;
HIGH RISK POPULATION;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
INFECTION CONTROL;
LABORATORY DIAGNOSIS;
LUNG INFECTION;
PREVALENCE;
SURGICAL APPROACH;
TREATMENT INDICATION;
HUMANS;
MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;
NONTUBERCULOUS MYCOBACTERIA;
|
EID: 84922352042
PISSN: 02725231
EISSN: 15578216
Source Type: Journal
DOI: 10.1016/j.ccm.2014.11.006 Document Type: Editorial |
Times cited : (4)
|
References (0)
|